Earnings Preview: BRC Inc to Report Financial Results Post-market on March 03

Moomoo NewsFeb 25 20:00 ET

Biopharmaceutical Research Company (BRC) Announces Development and Regulatory Milestone Following Successful Type C CMC Meeting With FDA, Advancing Clinical Development of Multiple Therapeutic Candidates

PR NewswireJan 29 11:00 ET

Truist Removes Price Target From BRC Inc. on Volatility, Low Share Price, Keeps Hold Rating; Prior Price Target Was $4

MT NewswiresJan 28 07:41 ET · Ratings

Truist Financial Maintains BRC Inc(BRCC.US) With Hold Rating

Moomoo NewsJan 28 07:34 ET · Ratings

Truist Financial Remains a Hold on BRC (BRCC)

TipRanksJan 28 07:27 ET

Roth MKM Maintains BRC Inc(BRCC.US) With Hold Rating, Cuts Target Price to $3.5

Moomoo NewsJan 16 08:33 ET · Ratings